Recent Advances in the Studies of Molecular Mechanisms Regulating Multidrug Resistance in Cancer Cells


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Abstract—Here we present new approaches to better understanding multidrug resistance (MDR) development in cancer cells, such as identification of components of a complex process of MDR evolution. Recent advances in the studies of MDR are discussed: 1) chemotherapy agents might be involved in the selection of cancer stem cells resulting in the elevated drug resistance and enhanced tumorigenicity; 2) cell–cell interactions have a great effect on the MDR emergence and evolution; 3) mechanotransduction is an important signaling mechanism in cell–cell interactions; 4) proteins of the ABC transporter family which are often involved in MDR might be transferred between cells via microvesicles (epigenetic MDR regulation); 5) proteins providing cell-to-cell transfer of functional P-glycoprotein (MDR1 protein) via microvesicles have been investigated; 6) P-glycoprotein may serve to regulate apoptosis, as well as transcription and translation of target genes/proteins. Although proving once again that MDR is a complex multi-faceted process, these data open new approaches to overcoming it.

作者简介

A. Stavrovskaya

Blokhin Medical Research Center of Oncology

编辑信件的主要联系方式.
Email: astavrovskaya@yahoo.com
俄罗斯联邦, Moscow, 115478

E. Rybalkina

Blokhin Medical Research Center of Oncology

Email: astavrovskaya@yahoo.com
俄罗斯联邦, Moscow, 115478


版权所有 © Pleiades Publishing, Ltd., 2018
##common.cookie##